Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhPDGF-BB for Lateral Epicondylitis
NCT01746420Phase 2Completed
- Sponsor
- BioMimetic Therapeutics
- Start
- Dec 2012
- Primary completion
- Oct 2014
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of becaplermin in Lateral Epicondylitis (LET), sponsored by BioMimetic Therapeutics. Started Dec 2012; status: completed.
02
Drugs
becaplermin
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT01746420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01746420.